Every figure this model derived for THC, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.
This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.
| Figure | Value | XBRL tag | As at |
|---|---|---|---|
| capex | 992,000,000 | PaymentsToAcquirePropertyPlantAndEquipment |
2026-06-30 |
| cash | 2,172,000,000 | CashAndCashEquivalentsAtCarryingValue |
2026-06-30 |
| current assets | 7,827,000,000 | AssetsCurrent |
2026-06-30 |
| current liabilities | 5,567,000,000 | LiabilitiesCurrent |
2026-06-30 |
| equity | 4,658,000,000 | StockholdersEquity |
2026-06-30 |
| interest expense | 820,000,000 | InterestExpenseNonoperating |
2026-06-30 |
| ocf | 4,015,000,000 | NetCashProvidedByUsedInOperatingActivities |
2026-06-30 |
| revenue | 21,812,000,000 | RevenueFromContractWithCustomerExcludingAssessedTax |
2026-06-30 |
| sbc | 132,000,000 | ShareBasedCompensation |
2026-06-30 |
The figures themselves rather than their scores — what somebody looking up THC on one particular measure came for.
| Ratio | Value |
|---|---|
| cash operating margin | 25.51 |
| current ratio | 1.41 |
| current ratio reported | 1.41 |
| dilution pct | -7.21 |
| ebit cagr | 20.97 |
| ebit yoy | 23.48 |
| fcf margin | 13.86 |
| growth cv | 1.11 |
| interest cover | 5.54 |
| net debt ebitda | 2.04 |
| operating margin | 20.81 |
| owner earnings margin | 13.25 |
| revenue growth | 5.41 |
| revenue growth per share | 13.59 |
| roic | 22.79 |
| rpo growth | -68.76 |
| rule of 40 | 26.22 |
| sbc pct revenue | 0.61 |
What this model itself distrusts about THC's figures. Written by the derivation as it ran, not added afterwards.